MAAT INDEX

CLAIM #56586 · Thermo Fisher Scientific Inc (TMO) · 2025Q3 earnings call · Oct 22, 2025 · due Dec 31, 2025

Looking to Q4, given the tariffs increased from the time of our last guide most materially between U.S. and Europe. Our initial view is that that kind of assumptions we had around tariffs pretty much hold for Q4. So I'm not expecting a significant pickup in Q4.

Stephen Williamson · CFO

CANNOT_DETERMINE
versus commitment · official band 5 percent
Committed
Our initial view is that that kind of assumptions we had around tariffs pretty much hold for Q4. So I'm not expecting a significant pickup in Q4.
Reported
The FX impact was driven by continued volatility in rates during the quarter due to trade tensions. And represented an incremental 65 basis points of headwinds of margins relative to our prior guidance.

How to check this claim

Look at: Tariff/FX-related EPS impact (favorable or unfavorable) disclosed for Q4, as compared to the $0.11 favorable pickup reported in Q3

It came true if: Q4 tariff/FX-related EPS benefit is roughly in line with or less than the Q3 $0.11 pickup (i.e., no significant incremental pickup)

Where: Company Q4 earnings release and management commentary on Q4 earnings call (tariff/FX EPS impact disclosure)

In context

ry Brennan: Terrific. And then just a follow-up maybe to Steven. Just on the EPS impact and tariffs, could you just kind of level set? I know you gave the impact in the quarter, you said you mark to market the European tariffs, but you had the $0.50 potential from China. Think you recaptured some of that. Could you just kind bottom line, like how much ultimately kind of the tariff changes occurred and kind of what's happening in 4Q? Thank you. Stephen Williamson: Yes. Thanks, Dan. So when I think about the tariffs and the kind of the actual experience in Q3 came in favorably to what we'd had in the prior guide. In my prepared remarks, called out the $0.11 pickup, and that's a combination of tariffs and the related FX to, in terms of the changes in the kind of tariff and trade environment. Looking to Q4, given the tariffs increased from the time of our last guide most materially between U.S. and Europe. Our initial view is that that kind of assumptions we had around tariffs pretty much hold for Q4. So I'm not expecting a significant pickup in Q4. That's kind of how we've kind of framed the guidance for in terms of this update. Operator: Great. Thanks, Sam. Our next question is from Andrew Tupa from Raymond James. Your line is open. Please go ahead. Andrew Tupa: Great. Thanks everybody for the time. Just first, would love a little bit more color on the contract research side of the house and maybe in particular, how that accelerator bundled program has gained traction and kinda layering that into the context of all the discussion that's already occurred in terms of onshoring, how that changes the applicability to customers, and how they look at know, that kind of wraparound March partnership versus, CRO and CDMO kinda separately historically? Marc Casper: Yeah. So, Andrew, thank you for the question. So when I think about accelerat

Verify independently

SEC filings for TMO · Claim quote is verbatim from the 2025Q3 earnings call.